Abstract
Diabetic nephropathy is the leading cause of end-stage renal disease in the United States and the largest contributor to the total cost of diabetic care. In addition to the development of diabetic nephropathy and end-stage renal failure, diabetic patients with evidence of albuminuria have a much higher risk of developing myocardial infarctions, cerebrovascular accidents, severe progressive retinopathy, and neuropathy. This article characterizes the clinical and pathologic features of diabetic nephropathy and reviews the major pathogenetic theories that underline the development of this dreaded complication of diabetes. Wide-spread screening of this condition and aggressive treatment of diabetic nephropathy at early stages of disease are critical to diminish the risk of costly late complications.
| Original language | English |
|---|---|
| Pages (from-to) | 111-146 |
| Number of pages | 36 |
| Journal | Clinics in Laboratory Medicine |
| Volume | 21 |
| Issue number | 1 |
| State | Published - 2001 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- Diabetic Nephropathies/complications
- Humans
- Kidney Glomerulus/pathology
Fingerprint
Dive into the research topics of 'Diabetic nephropathy'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver